News
-
-
PRESS RELEASE
Sanofi: Disclosure of trading in own shares
-
-
PRESS RELEASE
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
Dupixent outperformed Xolair in treating chronic rhinosinusitis with nasal polyps and coexisting asthma, showing superior efficacy across all key endpoints in a phase 4 study presented at EAACI -
-
-
-
PRESS RELEASE
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season, ensuring broad availability and high efficacy for infants -
-